Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.6.5 was issued, replacing v3.6.4. This reflects a backend/page-system update with no new study details or visible content changes indicated.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows a new revision tag (v3.6.4). The revision history now lists v3.6.4 as the current version, replacing the previous v3.6.3.SummaryDifference0.1%

- Check27 days agoChange DetectedNew schedule milestones were added to the study record, including the latest update date and revised completion timelines that extend into 2027. Older milestone dates were removed, signaling an update to the study's expected timeline and status.SummaryDifference0.3%

- Check48 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3, indicating a newer revision of the study record page. This reflects internal maintenance and does not change the study data or primary content.SummaryDifference0.1%

- Check62 days agoChange DetectedIntroduces a recruitment notice and new navigation aids to help users understand and join the study; includes a minor formatting change to the Intervention header and a new revision tag (v3.6.0).SummaryDifference0.4%

- Check69 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a new build/version of the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.